Trade PBYI

Puma Biotechnology Inc

-

00:00:00

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company’s drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Read More

PBYI
Trading Specifications

Digits

3

Point

0.001

Spread

floating

Contract Size

1

Volume Min

1

Volume Max

10,000

Volume Step

1

Swap Long (Points)

-0.610

Swap Short (Points)

-0.360
Available on
MT5, TV, cTrader
Last update at February 23, 21:09 GMT+2
*Data Source: MT5 Server Prime Account Pricing

1D Change

0.136%

Why BlackBull Markets?

26k+

Tradable Assets

1:500

Leverage up to

Regulated

Multi-Regulated

24/7

Customer Support

$0

No Minimum Deposit

Margin Calculator

Calculation Results

Current Price

6.52

Required Margin

Converted Currency

Required Margin

Account Based Currency

Join Now